Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Fragment Based Lead Discovery

Doris Hafenbradl's Biography

Doris Hafenbradl, Senior Director, Biofocus

Dr. Doris Hafenbradl joined BioFocus in December 2009 and is responsible for the hit finding activities and the natural products platform in Basel, Switzerland. Doris joined BioFocus from Proteros Biostructures where, as Executive VP, she was responsible for the strategic business and scientific development of the screening and proteins business unit. Prior to this Doris held senior positions within GPC Biotech and Axxima Pharmaceuticals AG, (both in Germany) leading drug discovery efforts to find kinase inhibitors in infectious diseases, inflammation and oncology. At the Genomics Institute of the Novartis Research Foundation in San Diego (CA, USA) she built a platform for antibacterial drug discovery. Doris holds an MS and PhD in Microbiology from the University of Regensburg, Germany.

Doris Hafenbradl Image

Fragment Based Drug Discovery - Getting in Shape

Wednesday, 14 March 2012 at 11:15

Add to Calendar ▼2012-03-14 11:15:002012-03-14 12:15:00Europe/LondonFragment Based Drug Discovery - Getting in

A comparison of fragment screening technologies SPR, Fluorescence Lifetime Technology, Caliper LC3000 and Thermophoresis demonstrates the strength of each approach. Besides the screening method also the selection and design of fragments is key. Shape and flexibility are some of the new parameters.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonFragment Based Lead